Articles tagged with Photoreceptors
A new study reveals that photoreceptors possess an internal recycling system that removes damaged proteins and maintains cellular health. This discovery has important implications for inherited retinal diseases and raises questions about the safety of certain drugs in clinical testing.
Researchers identified three amino acid changes that account for the 30 nm difference in light absorption between red and green cone pigments, enabling precise color discrimination. The study's findings may inform future drug discovery efforts targeting visual photoreceptors.
A new class of photoswitchable small molecule drugs has been developed to restore key visual functions in animal models of blindness. These compounds mimic the function of photoreceptor cells and show remarkable effectiveness at restoring sight using a simple and potentially patient-friendly approach.
Researchers study blind Mexican cavefish to understand how evolution rewires the brain and shapes behavior. They found that cavefish become more active in light, a response believed to help them avoid predators.
A team at Scripps Research has discovered that erucamide, a naturally occurring molecule, plays a key role in how the retina copes with disease. Restoring erucamide levels activates cellular responses that support retinal stability, slowing aspects of degeneration by preserving structure and function.
Researchers at Johns Hopkins University used lab-grown retinal tissue to discover the cellular mechanisms that shape the foveola, a critical part of the eye responsible for sharp vision. The findings suggest that blue cones convert into red and green cones during early development, rather than migrating to other parts of the retina.
Researchers discovered a unique photoreceptor cell that optimizes vision in low-light conditions, combining the benefits of both cone and rod cells. This finding has potential applications in developing more efficient cameras and medical treatments for eye conditions such as glaucoma.
Researchers have identified the cells and connections underlying a fish's ability to dynamically change color to match its surroundings. The study found that specialized skin cells called melanophores control the color change, which helps the zebrafish evade predators by lightening its skin over tens of minutes.
Researchers at the University of Cambridge found that the human eye has a resolution limit, above which screens provide more information than can be detected. For an average UK living room, a 44-inch 4K or 8K TV does not offer additional benefits over a lower resolution Quad HD TV.
Professor John O'Brien's research focuses on understanding the impact of electrical synapses and gap junction plasticity on the retina and other neurological functions. The study aims to identify proteins that control electrical synapse strength, shedding light on their role in human disorders such as autism and seizures.
A new treatment for corneal scarring is being developed by University of Houston optometry researcher Tarsis G. Ferreira. The treatment uses a natural protein called decorin to block scarring and unwanted blood vessel growth, offering hope for people with injured corneas.
In a breakthrough study, researchers at the University of Rochester Medical Center found that microglia cells respond differently than neutrophils to photoreceptor damage in the retina. This discovery has high implications for treating vision loss caused by photoreceptor cell damage.
Researchers at Flinders University found that blue-enriched light can make people less sensitive to losses, leading to riskier gambling behaviors. The study suggests that reducing blue light exposure could be a potential strategy to mitigate impulsive gambling.
Researchers at the University of Pennsylvania developed novel promoters that drive specific gene expression in rod and cone photoreceptors, outperforming most currently used promoters. These tools address the challenge of treating advanced stages of inherited retinal diseases, potentially restoring vision.
Researchers have developed a novel surgical technique to implant multiple tissue grafts in the eye's retina, expanding treatment options for dry AMD. The new method, which maintains eye pressure during graft insertion, promotes photoreceptor survival and regeneration of the choriocapillaris.
Researchers investigated genetic and sensory mechanisms behind mate preferences in Heliconius cydno butterflies with yellow or white wing patches. They found that males prefer females with matching wing colors due to differences in how sensory information is processed.
Researchers demonstrate the effectiveness of Ziapin2 in restoring ON, OFF, and ON-OFF responses induced by light stimuli in retinas with retinitis pigmentosa. The molecule restores light-induced behavior and visual acuteness for up to two weeks without toxic or inflammatory effects.
Zebrafish have pineal gland photoreceptors that detect color using parapinopsin 1 (PP1) protein. Two genes, Sagb and Arr3a, play a crucial role in the inactivation of PP1 based on light intensity, with Sagb taking over at higher intensities.
Researchers at TU Wien found that retinal ganglion cells retain their ability to produce different signals even after blindness. These intrinsic properties are stable and can be utilized in retinal implants, leading to better stimulation strategies for blind patients.
Fruit flies have a unique mechanism to maintain stable visual processing even when light levels change rapidly, thanks to the identification of neuronal cell types and algorithms that spatially pool information on luminance. This discovery could provide insights into how visual information is processed in mammals, including humans.
Researchers have introduced DSFN to improve the speed and accuracy of diagnoses of retinal disorders. This AI-powered medical imaging technique combines retina images with vascular distribution information to accurately locate the fovea in complex clinical scenarios, enabling doctors to detect early signs of ocular diseases.
Scientists have identified a novel photoreceptor in cyanobacteria that can detect green/teal light, breaking the typical red/green spectrum. The discovery highlights the remarkable diversity and editability of cyanobacteriochromes, expanding our understanding of how these organisms perceive color.
A team of scientists developed a method to quickly measure the frequency characteristics of photoreceptors' response to flicker stimulation, allowing for faster diagnosis of visual disorders. The new technique, called f-ORG, reduces the time required to conduct experiments and analyze data.
A pioneering CRISPR gene editing trial has demonstrated significant improvement in vision for 79% of participants with inherited retinal degeneration. The study's findings support further research into the potential of CRISPR-based treatments for inherited blindness.
Researchers used fMRI to assess brain responses to lights stimulating only cone cells in dogs with different types of retinal diseases. The study found that gene augmentation therapy restored response in cortex to black and white stimulation, making this disease a promising one for photoreceptor cell replacement treatment.
Researchers found that intrinsically-photosensitive retinal ganglion cells (ipRGCs) use both microvillous and ciliary signaling mechanisms simultaneously. This discovery reveals a new pathway for transmitting light signals to the brain, which may have ancient origins on the evolutionary scale.
A new camera system records natural animal-view videos with high accuracy, enabling scientists to study animal behavior and navigation. The system uses four color channels, including UV light, to produce accurate video of how animals perceive colors.
Scientists at University of Cambridge create Highlighter tool that uses specific light conditions to activate defense mechanisms in plants, allowing them to 'talk' to humans about impending dangers such as disease outbreaks and heatwaves. The system utilizes optogenetics technology to control biomolecular processes at the cellular level.
A protein found in bacteria activates its enzymatic activity by up to 10,000 times when exposed to blue light, acting like an on-off switch. This discovery could lead to enhanced and optimized optogenetic tools and medical treatments.
Biologists found that underfed jumping spiders lose photoreceptors, key to their vision. The study suggests nutrition affects retinal and neuronal health, potentially leading to breakthroughs in treating macular degeneration.
Researchers have built a new model to examine Usher Syndrome, a leading cause of combined deafness and blindness. The model replicates the visual problems not addressed by previous models, offering insight into strategies for designing therapeutic interventions.
Researchers at Duke-NUS Medical School have achieved significant vision recovery in experimental models of damaged retinas using stem cells. The study marks a promising step towards potentially restoring vision in eye diseases characterized by photoreceptor loss.
A recent study revealed the key to a protein that commonly causes blindness, including its role in transporting toxic compounds out of the eye. Mutations in this protein can cause vision loss in diseases like Stargardt disease, which affects approximately 30,000 people nationwide.
A team from the National Eye Institute identified Reserpine as a compound that keeps light-sensitive photoreceptors alive in three models of Leber congenital amaurosis type 10, an inherited retinal ciliopathy disease. The study suggests a potential treatment strategy for addressing retinal ciliopathies caused by multiple genes.
Researchers used UK Biobank image and genomic data to uncover insights into rare retinal dystrophies, a leading cause of blindness in working-age adults. The study identified new genetic associations with the thickness of photoreceptor cell layers, offering new avenues for research and diagnosis.
Phytochromes play a dual role in seed germination of Aethionema arabicum, stimulating but also inhibiting germination. The study reveals that high light intensity and duration inhibit germination, while short exposure favors germination, indicating a genetic basis for adaptation to environmental requirements.
Researchers have identified a new genetic risk factor for adult-onset macular degeneration by combining multiple maps. The study reveals that variations in the TRPM1 gene promoter alter LHX2 transcription factor binding, reducing gene activity and increasing disease risk. This finding advances our understanding of AMD's complex pathology.
A new approach to gene therapy for inherited blindness uses lipid nanoparticles to deliver mRNA inside the eye, targeting light-sensitive cells and creating proteins that edit vision-harming gene mutations. The technology has shown promising results in animal studies, including mice and nonhuman primates.
Scientists have created eye tissue using patient stem cells and 3D bioprinting, providing a model for studying the genesis of age-related macular degeneration. The printed tissue exhibited patterns of early AMD, including drusen deposits and progression to late dry stage AMD.
Scientists have decoded the signals plants send themselves to initiate photosynthesis, a process turning sunlight into sugars. The newly identified proteins control communication between plant cells and organelles, potentially leading to breakthroughs in cancer research and improving crop yields.
Scientists discovered the first direct evidence that Stargardt-related ABCA4 gene mutations affect a layer of cells in the eye called the retinal pigment epithelium (RPE). The study suggests a therapeutic strategy for the disease, which currently lacks treatment.
Researchers at the National Eye Institute have discovered a mechanism by which an area of the protein RPE65 converts vitamin A into a form usable by photoreceptor cells. This finding provides better understanding of RPE65's function and will inform potential treatments for vision disorders linked to gene mutations.
Researchers have identified an endocannabinoid, 2-linoleoyl glycerol (2-LG), responsible for activating TRP channels in photoreceptor cells. This discovery sheds light on the visual transduction process and may have implications for other sensory systems.
A new study has partly restored the function of retina's cone receptors in two completely colorblind children using gene therapy. The treatment has been shown to activate previously dormant communication pathways between the retina and brain, drawing on the plastic nature of the developing adolescent brain.
Researchers identified Srrm3 as a master regulator gene for photoreceptor cells in the retina, which is critical for visual function. The study found that misregulation of alternative splicing and microexons can lead to devastating health impacts, including vision loss.
The new human cell line, ABC, was developed from retinal pigment epithelial cells and retains their properties, allowing for the study of events relevant to normal repair processes. The research may lead to discoveries in senescence gene programming, neuroprotection, and cellular replacement therapies for blinding eye diseases
Researchers found that the eyes of tadpoles undergo significant changes in gene expression and photoreceptor cell sensitivity to adapt to life on land. The study reveals that 42% of genes involved in vision changed between tadpole and juvenile frog stages, enabling better adaptation to a bluer light environment.
Researchers at Cold Spring Harbor Laboratory have discovered a way to regulate plant growth by manipulating proteins called UBP12 and UBP13, which helps control the amount of CRY2 photoreceptor in plants. This finding has potential applications in improving crop yields and informing cancer research.
Buck Institute researchers found that dietary restriction can extend lifespan in fruit flies due to changes in their circadian rhythms, particularly in the eye. The study suggests that the eye plays a role in regulating lifespan, which may have implications for human health and aging.
Scientists create genetically engineered mouse model that changes color in response to light, allowing them to isolate background noise from blood flow and enhance imaging techniques. This breakthrough enables researchers to observe internal physiology with unprecedented accuracy, paving the way for new treatments and therapies.
Researchers develop Spatio-Temporal Optical Coherence Tomography (STOC-T) to measure retinal flicker optoretinograms at high frequencies. This breakthrough allows fast and non-invasive assessment of photoreceptor function, paving the way for new treatments for eye diseases.
Researchers at Aalto University have discovered a dedicated neural pathway in the retina that can detect even the dimmest shadows possible. This breakthrough could lead to unprecedented resolution in probing visual diseases.
Researchers revived photoreceptor cells in human macula, responding to bright and dim lights. The study restores communication between retinal cells, transforming brain and vision research.
Researchers at Van Andel Institute have discovered a new, detailed molecular structure of PhyB, a vital photoreceptor in plants, which allows them to sense light and regulate their lifecycles. The findings may lead to breakthroughs in agricultural and bioengineering practices.
Researchers have developed a gene therapy that restores night vision in dogs with congenital stationary night blindness (CSNB), a condition affecting the ON bipolar cells. The treatment enables dogs to navigate mazes in dim light and has a lasting therapeutic effect, paving the way for potential human treatments.
Researchers at UCI discovered that AdipoR1 protein deficiency leads to ceramide accumulation in the retina, causing progressive photoreceptor cell death. A pharmacological treatment combining desipramine and L-cycloserine reduced ceramide levels, protecting photoreceptors and improving vision.
Researchers at RIKEN have developed a new retinal transplant technique by engineering human-derived retina sheets to lose bipolar cells, allowing better connections to host retinas and improved responses to light. The technique has shown substantial functional improvement in animal studies and is now poised for human clinical trials.
Researchers at WVU are studying the Musashi proteins to understand their role in retinal degeneration and develop a universal therapy. By investigating protein translation and gene suppression, they hope to identify potential pathways to boost protein production and slow vision loss.
Scientists have identified a crucial mechanism for Rhodopsin production in fruit flies, which may lead to a better understanding of retinitis pigmentosa and vision loss. The study reveals that the EMC protein complex is essential for the proper folding and insertion of Xport-A, a key chaperone of Rhodopsin.
Researchers are exploring how an engineered adeno-associated virus (AAV) can compensate for missing protein or swap out genetic mutations that cause vision problems. AAV has been found to be beneficial and is being used as a tool to deliver genes that work as they should.